You have 9 free searches left this month | for more free features.

Eslicarbazepine acetate

Showing 1 - 25 of 1,065

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Genetic and Clinical Factors for Serious Skin Reactions Among

Terminated
  • SCAR
  • Blood or Saliva
  • Philadelphia, Pennsylvania
    University of Pennsylvania Perlman School of Medicine
Jan 19, 2021

Partial-onset Seizures With or Without Secondary Generalisation Trial in Seoul (Zebinix 400mg, Placebo for Zebinix 400mg,

Completed
  • Partial-onset Seizures With or Without Secondary Generalisation
  • Zebinix 400mg
  • +5 more
  • Seoul, Korea, Republic of
    Whan In Pharm.
Jan 6, 2020

ZEBinix® Retention Rate in Epilepsy in Elderly Patients

Unknown status
  • Epilepsy
  • +3 more
  • Lyon, France
    Centre Hospitalier St Joseph St Luc
Jan 7, 2020

Partial Epilepsy Trial in Worldwide (800 mg QD Eslicarbazepine acetate, 1200 mg QD Eslicarbazepine acetate, Placebo)

Completed
  • Partial Epilepsy
  • 800 mg QD Eslicarbazepine acetate
  • +2 more
  • Mobile, Alabama
  • +161 more
Apr 29, 2021

Epilepsy Trial in Palo Alto (Eslicarbazepine, Carbamazepine)

Completed
  • Epilepsy
  • Palo Alto, California
    Stanford University
May 13, 2019

ZEDEBAC: Zebinix Effects in Dependency of Baseline Conditions

Completed
  • Focal Epilepsy
    • Multiple Locations, Germany
      (unnamed)
    Sep 11, 2019

    Epilepsy With Partial On-set Seizures Trial in Canada, United States (Eslicarbazepine acetate, Eslicarbazepine Acetate)

    Completed
    • Epilepsy With Partial On-set Seizures
    • Eslicarbazepine acetate
    • Eslicarbazepine Acetate
    • Mobile, Alabama
    • +54 more
    Jun 14, 2020

    Epilepsy Trial (ESL 800 mg, ESL 1200 mg, ESL 1600 mg)

    Completed
    • Epilepsy
    • ESL 800 mg
    • +3 more
    • (no location specified)
    Oct 12, 2018

    Intradialytic Hypotension Trial in Béthune, Caen (ACETATE based dialysate, CITRATE based dialysate)

    Not yet recruiting
    • Intradialytic Hypotension
    • ACETATE based dialysate
    • CITRATE based dialysate
    • Béthune, France
    • +1 more
    Jun 29, 2023

    Prostate Adenocarcinoma, Recurrent Prostate Carcinoma Trial in Houston (Abiraterone Acetate, Bicalutamide, Degarelix)

    Active, not recruiting
    • Prostate Adenocarcinoma
    • Recurrent Prostate Carcinoma
    • Abiraterone Acetate
    • +7 more
    • Houston, Texas
      M D Anderson Cancer Center
    Dec 5, 2022

    Infertility Trial in Xi'an (Biosimilar cetrorelix acetate, Reference cetrorelix acetate)

    Not yet recruiting
    • Infertility
    • Biosimilar cetrorelix acetate
    • Reference cetrorelix acetate
    • Xi'an, None Selected, China
      He Cai
    Sep 7, 2023

    Central Precocious Puberty Trial in Gyeonggi-do (Leuprolide Acetate 11.25 MG/ML)

    Recruiting
    • Central Precocious Puberty
    • Leuprolide Acetate 11.25 MG/ML
    • Gyeonggi-do, Korea, Republic of
      Ajou University medical center
    Aug 29, 2023

    FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma, FIGO Grade 2 Endometrial Endometrioid Adenocarcinoma, Metastatic

    Not yet recruiting
    • FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma
    • +4 more
    • Computed Tomography
    • +3 more
    • (no location specified)
    Sep 13, 2022

    Acetoacetate and Acetate Metabolism in Chronic Kidney

    Not yet recruiting
    • Kidney Failure, Chronic
    • PET scan metabolic day
    • (no location specified)
    Jul 20, 2023

    Prostatic Tumors, Metastatic Castration-Resistant Prostate Cancer Trial in Worldwide (Abiraterone Acetate, Prednisone,

    Active, not recruiting
    • Prostatic Neoplasms
    • Metastatic Castration-Resistant Prostate Cancer
    • Abiraterone Acetate
    • +2 more
    • Los Angeles, California
    • +6 more
    Jan 18, 2023

    Abnormal Uterine Bleeding, Tranexamic Acid, Estrogen Trial in Bangkok, Phaya Thai (Tranexamic acid 250 mg oral tablet, Progynova

    Not yet recruiting
    • Abnormal Uterine Bleeding
    • +3 more
    • Tranexamic acid 250 mg oral tablet
    • Progynova 1 mg oral tablet
    • Bangkok, Ratchathewi, Thailand
    • +1 more
    Sep 27, 2023

    Prostate Cancer, Metabolic Syndrome, Obesity Trial (Apple Cider Vinegar, Placebo)

    Not yet recruiting
    • Prostate Cancer
    • +6 more
    • Apple Cider Vinegar
    • Placebo
    • (no location specified)
    Mar 24, 2023

    Contraception Trial in Hershey (Norethindrone Acetate 5 MG, Norethindrone 0.35 MG)

    Recruiting
    • Contraception
    • Norethindrone Acetate 5 MG
    • Norethindrone 0.35 MG
    • Hershey, Pennsylvania
      Hershey Medical Center
    Jan 20, 2023

    Cataracts Infantile Trial in Barcelone (Clobetasol Propionate, Prednisolone acetate ophthalmic suspension, 1%)

    Recruiting
    • Cataracts Infantile
    • Clobetasol Propionate
    • Prednisolone acetate ophthalmic suspension, 1%
    • Barcelone, Spain
      Hospìtal Sant Joan de Deu
    Feb 1, 2023

    Nonalcoholic Fatty Liver, Nonalcoholic Steatohepatitis Trial in Yokohama (Experimental: 4 mg/day of WY-8678 (guanabenz acetate),

    Active, not recruiting
    • Nonalcoholic Fatty Liver
    • Nonalcoholic Steatohepatitis
    • Experimental: 4 mg/day of WY-8678 (guanabenz acetate)
    • Experimental: 8 mg/day of WY-8678 (guanabenz acetate)
    • Yokohama, Kanagawa, Japan
      Yokohama City University
    Sep 25, 2022

    Abiraterone Acetate in Indian Metastatic, Castration Resistant

    Withdrawn
    • Prostate Cancer
    • Abiraterone Acetate
    • Bangalore, India
    • +2 more
    Aug 15, 2022

    Prostate Cancer Trial in United States (Relugolix, Leuprolide Acetate)

    Recruiting
    • Prostate Cancer
    • Tucson, Arizona
    • +7 more
    Feb 1, 2023

    Metastatic Castration-resistant Prostate Cancer (mCRPC), Prostatic Tumors Trial (MK-5684, Dexamethasone, Fludrocortisone

    Not yet recruiting
    • Metastatic Castration-resistant Prostate Cancer (mCRPC)
    • Prostatic Neoplasms
    • (no location specified)
    Nov 21, 2023

    Advanced HR-positive and HER2-negative Breast Cancer; CDK4/6 Inhibitor Treatment Failed Trial in Hangzhou (dalpiciclib;

    Recruiting
    • Advanced HR-positive and HER2-negative Breast Cancer; CDK4/6 Inhibitor Treatment Failed
    • dalpiciclib; fluvestrant; compound gossypol acetate tablets
    • Hangzhou, Zhejiang, China
      zhejiangCH
    Nov 9, 2023

    Stroke, Acute Trial in Karachi (Sodium Chloride 0.9% infusion alone or in combination with Sodim acetate with normal saline in a

    Recruiting
    • Stroke, Acute
    • Sodium Chloride 0.9% infusion alone or in combination with Sodim acetate with normal saline in a ratio 1;1, 2;1 and 3;1
    • Karachi, Pakistan
      Aga Khan University
    May 19, 2023